文献速递湿疹皮炎与荨麻疹

荷兰版手部湿疹生活质量问卷(QOLHEQ)的验证

Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
PubMed 文献 · Br J Dermatol · 2019-11-24

本研究在成人手部湿疹患者中前瞻性验证荷兰版QOLHEQ的信效度、可重复性、反应度和可解释性。共300人参与,结构效度良好,ICCagreement为0·91,SDC为14·4分,MIC为11·5分。建议将≥15分的改善视为真实重要变化。

要点

  • 荷兰版QOLHEQ结构效度与可重复性良好,单评分效度高但反应度中等。
  • ICCagreement为0·91,SEMagreement为5·2分,SDC为14·4分,MIC为11·5分。
  • ≥15分的改善应视为荷兰人群中的真实重要变化。

核心结论

  • 荷兰版QOLHEQ结构效度和可重复性良好,单评分效度高,反应度中等。
  • ≥15分的改善应视为荷兰人群中的真实重要变化。

研究设计与样本

  • 前瞻性验证研究,纳入成人手部湿疹患者,在基线、1-3天后和4-12周三个时间点收集QOLHEQ及多个参考工具数据。
  • 基线时300人参与,54%为男性,平均年龄45岁。

主要发现

  • 重评分后的量表结构符合Rasch模型和结构方程模型。
  • ICCagreement为0·91(95%CI 0·85-0·94),SEMagreement为5·2分。
  • 预先制定的假设中,单评分效度80%被确认,反应度变化评分64%被确认。
  • SDC为14·4分,MIC为11·5分。

关键数值与推荐

  • ICCagreement 0·91(95%CI 0·85-0·94),SEMagreement 5·2分。
  • SDC 14·4分,MIC 11·5分。
  • ≥15分的改善视为真实重要变化。

临床怎么用

  • 荷兰版QOLHEQ可用于测量荷兰手部湿疹患者健康相关生活质量损害。
  • 解读评分变化时,≥15分改善可视为重要临床变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measurement instruments should be validated for use in the population for which they are intended. The Quality of Life in Hand Eczema Questionnaire (QOLHEQ) has been developed to measure impairment of health-related quality of life in patients with hand eczema. OBJECTIVES: To assess validity, reproducibility, responsiveness and interpretability of the Dutch version of the QOLHEQ. METHODS: This was a prospective validation study in adult patients with hand eczema. At three time points (T0 , baseline; T1 , after 1-3 days; T2 , after 4-12 weeks), data from the QOLHEQ and multiple reference instruments were collected. Scale structure was assessed using item response theory analysis and structural equation modelling (SEM). Single-score validity and responsiveness were tested with hypotheses on correlations with reference instruments. Concerning reproducibility, intraclass correlation coefficients (ICCagreement ) and standard error of agreement (SEMagreement ) were checked. Regarding interpretability, bands for severity of quality-of-life impairment were proposed. Also, smallest detectable change (SDC) and minimally important change (MIC) were determined. RESULTS: At T0 , 300 individuals participated in the study (54% were male, mean age 45 years). Rescoring of the scale structure fitted the Rasch model and the SEM. The ICCagreement was 0·91 (95% confidence interval 0·85-0·94) and the SEMagreement was 5·2 points. Of the a priori formulated hypotheses, 80% (single-score validity) and 64% (change scores for responsiveness) were confirmed. The SDC was 14·4 points and the MIC was 11·5 points. CONCLUSIONS: The Dutch version of the QOLHEQ has a good structural validity and reproducibility and has a high single-score validity and moderate responsiveness. An improvement of ≥ 15 points should be regarded as a real, important change within the Dutch population. What's already known about this topic? The Quality of Life in Hand Eczema Questionnaire (QOLHEQ) measures impairment of health-related quality of life (HRQoL) in patients with hand eczema. The QOLHEQ was validated in Germany and Japan, but the validity and interpretability of the Dutch version are unknown. What does this study add? This study shows that the Dutch QOLHEQ is a valid instrument to measure HRQoL impairment in Dutch patients with hand eczema, demonstrating good reliability and moderate responsiveness. Methods of item response theory are applied to assess and refine the scoring structure. Severity gradings to interpret single and change scores, specifically in Dutch patients, are proposed. What are the clinical implications of this work? The Dutch QOLHEQ can now be used to measure HRQoL impairment in Dutch patients with hand eczema.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Oosterhaven JAF, Ofenloch RF, Schuttelaar MLA, et al. Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ). Br J Dermatol. 2019. PMID: 31560803. doi:10.1111/bjd.18558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。